Revvity Inc (RVTY)
100.61
-0.47
(-0.46%)
USD |
NYSE |
May 03, 16:00
100.56
-0.05
(-0.05%)
After-Hours: 20:00
Revvity Enterprise Value: 14.61B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 14.61B |
| May 02, 2024 | 14.67B |
| May 01, 2024 | 14.85B |
| April 30, 2024 | 14.84B |
| April 29, 2024 | 15.15B |
| April 26, 2024 | 14.72B |
| April 25, 2024 | 14.79B |
| April 24, 2024 | 14.86B |
| April 23, 2024 | 14.97B |
| April 22, 2024 | 14.63B |
| April 19, 2024 | 14.64B |
| April 18, 2024 | 14.46B |
| April 17, 2024 | 14.60B |
| April 16, 2024 | 14.57B |
| April 15, 2024 | 14.82B |
| April 12, 2024 | 14.96B |
| April 11, 2024 | 15.58B |
| April 10, 2024 | 15.51B |
| April 09, 2024 | 15.86B |
| April 08, 2024 | 15.33B |
| April 05, 2024 | 14.82B |
| April 04, 2024 | 14.74B |
| April 03, 2024 | 14.82B |
| April 02, 2024 | 14.81B |
| April 01, 2024 | 14.94B |
| Date | Value |
|---|---|
| March 31, 2024 | 15.15B |
| March 28, 2024 | 15.27B |
| March 27, 2024 | 15.32B |
| March 26, 2024 | 15.07B |
| March 25, 2024 | 15.02B |
| March 22, 2024 | 15.05B |
| March 21, 2024 | 15.28B |
| March 20, 2024 | 15.23B |
| March 19, 2024 | 15.17B |
| March 18, 2024 | 15.16B |
| March 15, 2024 | 15.25B |
| March 14, 2024 | 15.25B |
| March 13, 2024 | 15.64B |
| March 12, 2024 | 15.74B |
| March 11, 2024 | 15.79B |
| March 08, 2024 | 15.80B |
| March 07, 2024 | 15.70B |
| March 06, 2024 | 15.55B |
| March 05, 2024 | 15.51B |
| March 04, 2024 | 15.70B |
| March 01, 2024 | 15.53B |
| February 29, 2024 | 15.83B |
| February 28, 2024 | 15.56B |
| February 27, 2024 | 15.34B |
| February 26, 2024 | 15.14B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.307B
Minimum
Mar 16 2020
29.80B
Maximum
Dec 30 2021
17.62B
Average
16.52B
Median
Enterprise Value Benchmarks
| Agilent Technologies Inc | 41.67B |
| Bruker Corp | 11.24B |
| Azenta Inc | 1.995B |
| Harvard Bioscience Inc | 199.37M |
| Bionano Genomics Inc | 26.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 26.01M |
| Revenue (Quarterly) | 649.92M |
| Total Expenses (Quarterly) | 605.80M |
| EPS Diluted (Quarterly) | 0.21 |
| Gross Profit Margin (Quarterly) | 54.63% |
| Profit Margin (Quarterly) | 4.00% |
| Earnings Yield | 1.20% |
| Operating Earnings Yield | 2.17% |
| Normalized Earnings Yield | 1.738 |